FDA asks NDMA for anticaries biological testing information.
This article was originally published in The Tan Sheet
Executive Summary
ANTICARIES BIOLOGICAL TESTING INFORMATION REQUESTED BY FDA in a May 24 letter to the Nonprescription Drug Manufacturers Association. Responding to an April 17 citizen petition submitted on behalf of an NDMA/Cosmetic, Toiletry and Fragrance Association joint task force, the letter states that the agency will not make a decision on whether to extend the effective date of the OTC anticaries final monograph biological testing requirements by 12 months (to Oct. 7, 1997) until the information has been received.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning